Basic Study
Copyright ©The Author(s) 2015.
World J Gastroenterol. May 7, 2015; 21(17): 5259-5270
Published online May 7, 2015. doi: 10.3748/wjg.v21.i17.5259
Table 1 Perfusion parameters for normal parenchyma, viable tumor component and whole tumor (n = 11) obtained using protocols A, B and C
HAP (mL/min per 100 mg)HPP (mL/min per 100 mg)HBF (mL/min per 100 mg)HPI (%)
Normal liver 120 kVp31.27 ± 9.2299.44 ± 22.99130.71 ± 31.0823.60 ± 3.99
80 kVp IR28.38 ± 9.4597.5 ± 22.11125.93 ± 29.1922.24 ± 4.55
80 kVp28.5 ± 9.5697.56 ± 22.02125.96 ± 29.3522.20 ± 4.34
P value0.7210.9740.9120.699
Viable tumor
120 kVp112.68 ± 50.2282.67 ± 25.21195.36 ± 72.3856.65 ± 6.42
80kVp IR108.94 ± 43.3583.83 ± 25.04192.77 ± 63.5655.66 ± 6.90
80 kVp106.76 ± 42.9983.91 ± 25.36192.49 ± 64.0855.46 ± 7.23
P value0.9540.9920.9940.909
Whole tumor
120 kVp102.06 ± 45.5381.65 ± 25.55183.71 ± 68.6654.60 ± 6.01
80 kVp IR96.71 ± 38.6981.99 ± 22.79178.70 ± 57.8153.10 ± 6.71
80 kVp99.48 ± 40.3283.37 ± 23.11182.85 ± 59.6353.22 ± 7.03
P value0.9560.9840.9800.842
Table 2 Quantitative image analysis (n = 11)
P value
80 kVp with IR80 kVp120 kVp80 IR vs 12080 vs 120
Normal liver
Arterial phase (HU)78.88 ± 7.178.61 ± 7.2771.57 ± 6.930.0410.049
Portal venous phase (HU)129.00 ± 5.70129.5 ± 5.67120.34 ± 5.260.0020.001
Viable tumor
Arterial phase (HU)131.68 ± 24.24131.74 ± 24.29122.15 ± 23.250.5520.549
Portal venous phase (HU)86.05 ± 12.8287.77 ± 13.3979.43 ± 10.590.3570.211
Noise
NoiseHAP (HU)9.31 ± 0.9413.85 ± 1.058.16 ± 0.950.019< 0.001
NoisePVP (HU)9.50 ± 0.9313.47 ± 1.278.27 ± 1.170.031< 0.001
CNR
CNRHAP5.63 ± 2.383.88 ± 1.826.16 ± 2.600.8140.048
CNRPVP4.60 ± 1.273.16 ± 1.045.11 ± 1.740.5870.004
Table 3 Contrast medium consumption (n = 11)
80 kVp120 kVpP value
Body weight (kg)3.0 ± 0.113.0 ± 0.11
Concentration of contrast medium (mgI/mL)270350
Volume of contrast medium (mL)45
Contrast medium dose (mgI/kg)360.1 ± 13.3583.5 ± 21.5< 0.001